Item 7.01 Regulation FD Disclosure.
The slide presentation to be used in investor meetings and presented at the Conference is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The furnishing of the attached slide presentation is not an admission as to the
materiality of any information therein. The information contained in the slides
is summary information that is intended to be considered in the context of more
complete information included in the Company's filings with the
The information contained in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or for any other purpose, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in any such filing, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Slide presentation ofAcceleron Pharma Inc. datedJanuary 11, 2021 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
--------------------------------------------------------------------------------
© Edgar Online, source